Cv Sciences

Top CBD companies’ lackluster sales, profits point to years-long national trend

08-Sep-2023 By Claudia Adrien

The US cannabidiol industry has seen a year-over-year decline in sales, despite attempts to bolster the CBD market with newer products.

CV Sciences reports 18% revenue drop for ‘challenging’ 2021

04-Apr-2022 By Stephen Daniells

San Diego-based CV Sciences, one of the bell-weather companies in the hemp and CBD space, has reported a decline in revenues for the past financial year, but new initiatives have positioned the company for long-term growth, says its CEO.

CV Sciences highlights new research that touts CBD safety, benefits

02-Jun-2020 By Danielle Masterson

Hemp cannabidiol (CBD) supplier and manufacturer CV Sciences just announced fresh research that demonstrates the safety and health benefits of its PlusCBD products.

Series of high-profile lawsuits challenging legal status of CBD products are stayed or voluntarily dismissed

29-May-2020 By Elaine Watson

Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods & supplements) or voluntarily dismissed in recent weeks.